Xenovium delivers drug discovery and development projects in partnership with Pharmaceutical and Biotech clients. Xenovium provides expertise, project leadership and delivery to milestones through access to a coordinated team of world-class R&D Associates with >250 years of collective experience. We provide an integrated offering, with expertise from Target Validation to Clinical Proof of Mechanism, including commercial and finance assessments, with an extensive skill base across multiple therapeutic areas. All work can be fully integrated with client skill sets or stand-alone and is outsourced and coordinated by Xenovium through a network of high quality Contract Research Organisations. Xenovium provides access to a dynamic team allowing different skills to be applied according to the phase of project, at a fraction of the cost of hiring a full-time team. We work with our clients to optimise their investment through our focus on the critical elements of each project at every phase. This is the Xenovium advantage – accelerating drug discovery and development.
Company Details
- Founded
- -
- Address
- Little Chesterford, Saffron Walden,essex Cb10 1xl,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- xenovium.com
- HQ
- Saffron Walden, Essex
Xenovium Questions
Xenovium's website is xenovium.com
Xenovium's LinkedIn profile is https://uk.linkedin.com/company/xenovium
Xenovium's industry is
Biotechnology Research
Xenovium's top competitors are
Ai Vivo,
Neophore Ltd,
Vianautis,
Charm Therapeutics,
Five Alarm Bio Limited,
Amphista Therapeutics Limited,
Pharmenable Therapeutics,
Storm Therapeutics Limited,
Nodthera,
Constructive Bio.
Xenovium's categories are Biotechnology Research
Xenovium's founding year is 2013
